MERCK KGAA NAM.SP.ADR - Asset Resilience Ratio

Latest as of December 2025: 1.16%

MERCK KGAA NAM.SP.ADR (MRKC) has an Asset Resilience Ratio of 1.16% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

€597.00 Million

≈ $697.96 Million USD Cash + Short-term Investments

Total Assets

€51.53 Billion

≈ $60.24 Billion USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2020–2025)

This chart shows how MERCK KGAA NAM.SP.ADR's Asset Resilience Ratio has changed over time. See MERCK KGAA NAM.SP.ADR leverage flexibility ratio to measure the company's free cash flow as a share of total liabilities.

Liquid Assets Composition Over Time

This chart breaks down MERCK KGAA NAM.SP.ADR's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see MRKC market cap overview.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	€0.00	0%
Short-term Investments	€597.00 Million	1.16%
Total Liquid Assets	€597.00 Million	1.16%

Asset Resilience Insights

Limited Liquidity: MERCK KGAA NAM.SP.ADR maintains only 1.16% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

MERCK KGAA NAM.SP.ADR Industry Peers by Asset Resilience Ratio

Compare MERCK KGAA NAM.SP.ADR's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Takeda Pharmaceutical Company Limited F:TKDA	Drug Manufacturers - Specialty & Generic	0.69%
Shanghai Haoyuan Chemexpress Co. Ltd. A SHG:688131	Drug Manufacturers - Specialty & Generic	1.37%
Beijing New Oriental Star Petrochemical Engineering Co Ltd SHE:002755	Drug Manufacturers - Specialty & Generic	24.59%
Zhejiang Hisoar Pharmaceutical Co Ltd SHE:002099	Drug Manufacturers - Specialty & Generic	0.20%
Celltrion Pharm Inc KQ:068760	Drug Manufacturers - Specialty & Generic	12.49%
Shanghai Yizhong Pharmaceutical Co Ltd SHG:688091	Drug Manufacturers - Specialty & Generic	26.36%
Heilongjiang ZBD Pharmaceutical Co Ltd SHG:603567	Drug Manufacturers - Specialty & Generic	0.00%
Zhejiang Anglikang Pharmaceutical Co Ltd Class A SHE:002940	Drug Manufacturers - Specialty & Generic	9.11%

Annual Asset Resilience Ratio for MERCK KGAA NAM.SP.ADR (2020–2025)

The table below shows the annual Asset Resilience Ratio data for MERCK KGAA NAM.SP.ADR.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	1.16%	€597.00 Million ≈ $697.96 Million	€51.53 Billion ≈ $60.24 Billion	+0.08pp
2024-12-31	1.08%	€558.00 Million ≈ $652.36 Million	€51.57 Billion ≈ $60.29 Billion	+0.19pp
2023-12-31	0.89%	€431.00 Million ≈ $503.88 Million	€48.49 Billion ≈ $56.70 Billion	+0.39pp
2022-12-31	0.50%	€244.00 Million ≈ $285.26 Million	€48.53 Billion ≈ $56.74 Billion	+0.26pp
2021-12-31	0.25%	€112.00 Million ≈ $130.94 Million	€45.36 Billion ≈ $53.03 Billion	+0.18pp
2020-12-31	0.07%	€29.00 Million ≈ $33.90 Million	€41.80 Billion ≈ $48.86 Billion	--

pp = percentage points

About MERCK KGAA NAM.SP.ADR

F:MRKC Germany Drug Manufacturers - Specialty & Generic

Market Cap

$17.07 Billion

€14.60 Billion EUR

Market Cap Rank

#1457 Global

#326 in Germany

Share Price

€22.60

Change (1 day)

-2.59%

52-Week Range

€20.20 - €26.20

All Time High

€44.30